• Publications:
• Assessment of nivolumab in HIV-Infected patients with advanced non-small cell lung cancer after prior chemotherapy. The IFCT-1602 CHIVA2 phase 2 clinical trial
• IFCT-1602 CHIVA2 phase II trial: Nivolumab in previously treated HIV-patients with advanced nonsmall cell lung cancer (NSCLC)
• Impact of Anti PD-1 Immunotherapy on HIV Reservoir and Anti-Viral Immune Responses in People Living with HIV and Cancer
• Synopsis: IFCT-1602_CHIVA2_Synopsis_v1.4_110219.pdf